Cancer Research Grant and Funding Opportunities

• Program Announcement PA-CA-08-165: http://grants.nih.gov/grants/guide/pa-files/PA-08-165.html 
• Application Receipt Date(s): Standard receipt dates apply
• This funding opportunity encourages research in all aspects of tumor stem cell biology, including the molecular and biochemical regulation of embryonic and adult stem cell behavior relevant to tumor formation.  As with all R21 funding mechanisms, this funding is intended for exploratory or developmental projects.

• Request for Applications RFA-CA-08-019: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-019.html 
• Letter of Intent Receipt Date: April 12, 2008
• The purpose of this announcement is to stimulate research in the area of tumor stem cell biology including characterization of tumor stem cell markers, and to identify specific genetic and functional signatures of tumor stem cells, with the goal to translating basic research findings into clinical practice in the context of both hematological and solid tumor malignancies.
• Funds totaling $2.7M have been set aside for the RFA.

• Request for Applications  RFA-CA-08-017: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-017.html 
• Letter of Intent Receipt Date: April 14, 2008
• The purpose of this announcement is to solicit grant applications for research projects focused on the development and application of comparative (cross-species) systems genetics approaches to address key cancer-relevant problems, and which will use these approaches to enhance the understanding of the mechanisms that underlie both human cancer susceptibility and human tumor heterogeneity.
• Funds totaling $3M per year have been set aside for the RFA.

• Program Announcement  PAR-08-055: http://grants.nih.gov/grants/guide/pa-files/PAR-08-055.html 
• Application Receipt Date(s): March 19, 2008; July 18, 2008; December 19, 2008; March 20, 2009; July 17, 2009; December 18, 2009; March 19, 2010; July 19, 2010; and, December 9, 2010.
• The purpose of this announcement is to enhance basic and applied cancer prevention research.  Examples could include projects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science and/or clinical prevention studies that focus on specific target organs.  As with all R03 proposals, the intent is to fund pilot and feasibility studies; secondary analyses of existing data; small, self-contained research projects; and, development of new research methodologies or technologies.
• Budgets for direct costs up to $50,000 per year for up to 2 years may be proposed.  

• Program Announcement  PAR-07-420: http://grants.nih.gov/grants/guide/pa-files/PAR-07-420.html 
• Application Receipt Date(s): Standard receipt dates apply
• The purpose of this announcement is to stimulate research on the biology of the lymphatic system at all biologic levels: molecular, cellular, tissue, organs and whole body levels; including research on innovations for identifying and intervening in lymphatic diseases such as cancer.  More detail on the research opportunities as they related to cancer can be found on this Notice: NOT-CA-07-022:  http//grants.nih.gov/grants/guide/notice-files/NOT-CA-07-022.html

• Program Announcement PA-07-356: http://grants1.nih.gov/grants/guide/pa-files/PA-07-356.html 
• Application Receipt Date(s): Standard receipt dates apply
• The purpose of this announcement is to stimulate the development of innovative cancer prevention and therapy clinical trials with or without laboratory correlative studies, and to support innovative correlative laboratory studies retrospectively and prospectively linked to therapeutic/preventive clinical trials.

• Program Announcement Number PA-06-371: http://grants1.nih.gov/grants/guide/PA-files/PA-06-371.html
• Application Receipt Date(s): Standard receipt dates apply
• The Cancer Imaging Program (CIP) of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental applications that articulate high risk and/or high impact research focused on in vivo cancer imaging for detection, diagnosis, and monitoring of response to therapy. 

• Program Announcement PA-05-015: http://grants1.nih.gov/grants/guide/pa-files/PA-05-015.html 
• Application Receipt Date(s): Applications can be received at any time
• Principal Investigators holding specific types of NIH research grants are eligible for administrative supplements to improve the diversity of the research workforce by supporting and recruiting students, post-doctorates, and eligible investigators from groups that have been shown to be underrepresented minorities.

• Notice Number NOT-CA-07-003: http://grants1.nih.gov/grants/guide/notice-files/NOT-CA-07-003.html
• Receipt Date: Request-for-validation-support letters containing descriptions of biomarkers meeting the eligibility criteria are accepted on a continuous basis throughout the year.
• Interested investigators are invited to submit two- to three-page-long (maximum) descriptions of their biomarkers, though a separate request-for-validation-support letter will be required for each organ site. Funding for PRIDE will be provided through the EDRN's Set-Aside funds for biomarker validations.

• Prostate Cancer Research Awards -- Eleven different funding mechanisms are available, with $80 million to be awarded in 2008.  Description can be found at the Prostate Cancer Research Program (PCRP) website, and includes idea development, new investigator, synergistic idea, clinical trial, and clinical consortium awards.  Pre-application submission deadlines begin on May 22 or June 11. 

Simmons Comprehensive Cancer Center - Clinical Trial Development Funds

• These awards provide funds to UT Southwestern faculty for innovative, investigator-initiated therapeutic oncology clinical and translational patient-oriented trials.  Two proposals per year (July and December) will be funded at $50,000 each.  The intent of these funds is to support rapid translation of UTSW science to cancer patients.
• For more information, please download the RFA and CTDF Application.

Simmons Cancer Center/American Cancer Society - New Investigators Awards

• Deadline: May 16, 2008  
• These awards are intended to provide support to new cancer investigators at UT Southwestern who have an appointment as an Assistant Professor and who are within 6 year of their first independent faculty appointment.
• These awards provide up to $40,000 for 1-year of support for a focused project in cancer research.
• For more information, please download the IRG Announcement and the IRG Application.    

Damon Runyon Cancer Research Foundation -- Innovation Award

• Deadline (pre-proposals): June 2 
• These awards provide support for the next generation of exceptionally creative thinkers with "high risk/high reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis and treatment of cancer.
• The awards will provide $450,000 in direct costs over 3 years, and a maximum of 5 awards will be granted each year.
• Go the website for more information on the program, along with the application:  www.damonrunyon.org.

American Cancer Society -- Research Scholar Grants

• Deadlines: April 1, and October 15 
• Contact: www.cancer.org
• These grants provide funding to investigators for projects in basic, pre-clinical, clinical, cancer control and epidemiologic research.  Awards are up to 4 years and for up to $200,000 per year (direct costs), with 20% allowable for indirect costs.

Charlotte Geyer Foundation Grants

• Deadlines: February 1, June 1, and October 1 
• Contact: http://www.charlottegeyer.org/apply.html
• These grants provide interim funding to researchers whose original (e.g., no A1 or A2) proposals have been reviewed by the NCI and were ranked within twenty percentage points of the NCI payline; they can provide up to $100,000 per year in funding.